Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Tumori|September 23, 2024
Is tumour sequencing effective for the identification of germline BRCA1/2 pathogenic variant carriers?Jacopo Azzollini, Iolanda Capone, Matteo Duca, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 30, 2025
FOLFOX Versus FOLFIRI as Second-Line Chemotherapy in Patients With Advanced Biliary Tract Cancers: A Multicenter, Italian StudyChiara Pircher, Federico Nichetti, Mario Domenico Rizzato, et al.
Clinical Colorectal Cancer|June 10, 2020
Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak: COVID-19-adapted Recommendations of the National Cancer Institute of MilanFilippo Pietrantonio, Federica Morano, Monica Niger, et al.
JCO Precision Oncology|June 11, 2025
Real-World Outcomes of Molecular Tumor Board Treatment RecommendationsFederico Nichetti, Marta Brambilla, Matteo Duca, et al.
Journal of Thrombosis and Haemostasis : JTH|May 13, 2020
Thrombin generation predicts early recurrence in breast cancer patientsMarina Marchetti, Cinzia Giaccherini, Giovanna Masci, et al.
Scientific Reports|November 6, 2022
Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinomaMargherita Rimini, Carles Fabregat-Franco, Valentina Burgio, et al.
Clinical Colorectal Cancer|December 19, 2018
Perioperative Bevacizumab-based Triplet Chemotherapy in Patients With Potentially Resectable Colorectal Cancer Liver MetastasesFilippo Pietrantonio, Christian Cotsoglou, Giovanni Fucà, et al.
European Journal of Cancer (Oxford, England : 1990)|June 24, 2022
Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinomaMargherita Rimini, Teresa Macarulla, Valentina Burgio, et al.
Targeted Oncology|January 23, 2023
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma PatientsMargherita Rimini, Carles Fabregat-Franco, Mara Persano, et al.
Journal of Hematology & Oncology|December 15, 2023
Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors: the phase Ib trial MetNET2Sara Pusceddu, Francesca Corti, Natalie Prinzi, et al.
Pageof 8